2,834
Views
90
CrossRef citations to date
0
Altmetric
Research Article

Nanotransfersomes of carvedilol for intranasal delivery: formulation, characterization and in vivo evaluation

, , &
Pages 2471-2481 | Received 28 Nov 2014, Accepted 27 Jan 2015, Published online: 26 Feb 2015

References

  • Aboelwafa AA, El-Setouhy DA, Elmeshad AN. (2010). Comparative study on the effects of some polyoxyethylene alkyl ether and sorbitan fatty acid ester surfactants on the performance of transdermal carvedilol proniosomal gel using experimental design. AAPS PharmSciTech 11:1591–602
  • Aburahma MH. (2014). Bile salts-containing vesicles: promising pharmaceutical carriers for oral delivery of poorly water-soluble drugs and peptide/protein-based therapeutics or vaccines. Drug Deliv 12:1–21
  • Ahad A, Aqil M, Kohli K, et al. (2012). Formulation and optimization of nanotransfersomes using experimental design technique for accentuated transdermal delivery of valsartan. Nanomedicine 8:237–49
  • Al-Ghananeem AM, Sandefer EP, Doll WJ, et al. (2008). Gamma scintigraphy for testing bioequivalence: A case study on two cromolyn sodium nasal spray preparations. Int J Pharm 357:70–6
  • Allen TM. (1981). A study of phospholipid interactions between high-density lipoproteins and small unilamellar vesicles. Biochim Biophys Acta 640:385–97
  • Alsarra IA, Hamed AY, Alanazi FK. (2008). Acyclovir liposomes for intranasal systemic delivery: development and pharmacokinetics evaluation. Drug Deliv 15:313–21
  • Arumugam K, Subramanian GS, Mallayasamy SR, et al. (2008). A study of rivastigmine liposomes for delivery into the brain through intranasal route. Acta Pharm 58:287–97
  • Bancroft DJ, Gamble M. (2007). Theory and practice of histological techniques, 7th ed. USA: Churchill Livingstone
  • Bangham AD, Standish MM, Watkins JC. (1965). Diffusion of univalent ions across the lamellae of swollen phospholipids. J Mol Biol 13:238–52
  • Barenholz Y. (2003). Relevancy of drug loading to liposomal formulation therapeutic efficacy. J Liposome Res 13:1–8
  • Callens C, Ceulemans J, Ludwing A, et al. (2003). Rheological study on mucoadhesivity of some nasal powder formulations. Eur J Pharm Biopharm 55:323–8
  • Cevc G, Blume G. (2003). Biological activity and characteristics of triamcinolone-acetonide formulated with the self-regulating drug carriers, Transfersomes. Biochim Biophys Acta 1614:156–64
  • Cevc G, Blume G. (2004). Hydrocortisone and dexamethasone in very deformable drug carriers have increased biological potency, prolonged effect, and reduced therapeutic dosage. Biochim Biophys Acta 1663:61–73
  • Chavanpatil MD, Vavia PR. (2004). The influence of absorption enhancers on nasal absorption of acyclovir. Eur J Pharm Biopharm 57:483–7
  • Cheng Y, Watts P, Hinchcliffe M, et al. (2002). Development of a novel nasal nicotine formulation comprising an optimal pulsatile and sustained plasma nicotine profile for smoking cessation. J Control Release 79:243–54
  • Comiskey SJ, Heath TD. (1990). Serum-induced leakage of negatively charged liposomes at nanomolar lipid concentrations. Biochemistry 29:3626–31
  • Ding WX, Qi XR, Fu Q, Piao HS. (2007). Pharmacokinetics and pharmacodynamics of sterylglucoside-modified liposomes for levonorgestrel delivery via nasal route. Drug Deliv 14:101–4
  • Dora CP, Singh SK, Kumar S, et al. (2010). Development and characterization of nanoparticles of glibenclamide by solvent displacement method. Acta Pol Pharm 67:283–90
  • Dubey V, Mishra D, Nahar M, Jain NK. (2008). Elastic liposomes mediated transdermal delivery of an anti-jet lag agent: preparation, characterization and in vitro human skin transport study. Curr Drug Deliv 5:199–206
  • El Maghraby GM, Williams AC, Barry BW. (2000). Oestradiol skin delivery from ultradeformable liposomes: refinement of surfactant concentration. Int J Pharm 196:63–74
  • El Zaafarany GM, Awad GA, Holayel SM, Mortada ND. (2010). Role of edge activators and surface charge in developing ultradeformable vesicles with enhanced skin delivery. Int J Pharm 397:164–72
  • Fang JY, Yu SY, Wu PC, et al. (2001). In vitro skin permeation of estradiol from various proniosome formulations. Int J Pharm 215: 91–9
  • Gavini E, Rassu G, Sanna V, et al. (2005). Mucoadhesive microspheres for nasal administration of an antiemetic drug, metoclopramide: in-vitro/ex-vivo studies. J Pharm Pharmacol 57:287–94
  • Ghirardelli R, Bonasoro F, Porta C, Cremaschi D. (1999). Identification of particular epithelial areas and cells that transport polypeptide-coated nanoparticles in the nasal respiratory mucosa of the rabbit. Biochim Biophys Acta 1416:39–47
  • Guinedi AS, Mortada ND, Mansour S, Hathout RM. (2005). Preparation and evaluation of reverse-phase evaporation and multilamellar niosomes as ophthalmic carriers of acetazolamide. Int J Pharm 306:71–82
  • Gupta A, Aggarwal G, Singla S, Arora R. (2012). Transfersomes: a novel vesicular carrier for enhanced transdermal delivery of sertraline: development, characterization and performance evaluation. Sci Pharm 80:1061–80
  • Haggag RS, Shaalan RA, Belal TS. (2010). Validated HPLC determination of the two fixed dose combinations (chlordiazepoxide hydrochloride and mebeverine hydrochloride; carvedilol and hydrochlorothiazide) in their tablets. J AOAC Int 93:1192–200
  • Harris AS, Ohlin M, Svensson E, et al. (2006). Effect of viscosity on the pharmacokinetics and biological response to intranasal desmopressin. J Pharm Sci 78:470–1
  • Hiruta Y, Hattori Y, Kawano K, et al. (2006). Novel ultra-deformable vesicles entrapped with bleomycin and enhanced to penetrate rat skin. J Control Release 113:146–54
  • Honeywell-Nguyen PL, Arenja S, Bouwstra JA. (2003). Skin penetration and mechanisms of action in the delivery of the D2-agonist rotigotine from surfactant-based elastic vesicle formulations. Pharm Res 20:1619–25
  • Honeywell-Nguyen PL, Bouwstra JA. (2003). The in vitro transport of pergolide from surfactant-based elastic vesicles through human skin: a suggested mechanism of action. J Control Release 86:145–56
  • Ishida T, Harashima H, Kiwada H. (2002). Liposome clearance. Biosci Rep 22:197–224
  • Jain S, Jain P, Umamaheshwari RB, Jain NK. (2003). Transfersomes – a novel vesicular carrier for enhanced transdermal delivery: development, characterization, and performance evaluation. Drug Dev Ind Pharm 29:1013–26
  • Kim S, Lee HS, Lee HJ. (2010). Rapid and sensitive carvedilol assay in human plasma using a high-performance liquid chromatography with mass/mass spectrometer detection employed for a bioequivalence study. AJAC 1:135–43
  • Kumar A, Pathak K, Bali V. (2012). Ultra-adaptable nanovesicular systems: a carrier for systemic delivery of therapeutic agents. Drug Discov Today 17:1233–41
  • Lee EH, Kim A, Oh YK, Kim CK. (2005). Effect of edge activators on the formation and transfection efficiency of ultradeformable liposomes. Biomaterials 26:205–10
  • Lopes LB, Scarpa MV, Silva GV, et al. (2004). Studies on the encapsulation of diclofenac in small unilamellar liposomes of soya phosphatidylcholine. Colloids Surf B Biointerfaces 39:151–8
  • Mahajan HS, Gattani S. (2010). In situ gels of metoclopramide hydrochloride for intranasal delivery: in vitro evaluation and in vivo pharmacokinetic study in rabbits. Drug Deliv 17:19–27
  • Mainardes RM, Urban MC, Cinto PO, et al. (2006). Liposomes and micro/nanoparticles as colloidal carriers for nasal drug delivery. Curr Drug Deliv 3:275–85
  • Manconi M, Mura S, Sinico C, et al. (2009). Development and characterization of liposomes containing glycols as carriers for Diclofenac. Colloids Surf A: Physicochem Eng Asp 342:53–8
  • Manconi M, Valenti D, Sinico C, et al. (2003). Niosomes as carriers for tretinoin: II. Influence of vesicular incorporation on tretinoin photostability. Int J Pharm 260:261–72
  • Mao S, Chen J, Wei Z, et al. 2004. Intranasal administration of melatonin starch microspheres. Int J Pharm 272:37–43
  • Marttin E, Verhoef JC, Chullander C, et al. (1997). Confocal laser scanning microscopic visualization of the transport of dextran after nasal administration to rats: effects of absorption enhancers. Pharm Res 14:631–7
  • Mu X, Zhong Z. (2006). Preparation and properties of poly(vinly alcohol)-stabilized liposomes. Int J Pharm 318:55–61
  • Muramatsu K, Maitani Y, Takayama K, Nagai T. (1999). The relationship between the rigidity of the liposomal membrane and the absorption of insulin after nasal administration of liposomes modified with an enhancer containing insulin in rabbits. Drug Dev Ind Pharm 25:1099–105
  • Nasr M, Mansour S, Mortada ND, Elshamy AA. (2008). Vesicular aceclofenac systems: a comparative study between liposomes and niosomes. J Microencapsul 25:499–512
  • Nema T, Jain A, Jain A, et al. (2013). Insulin delivery through nasal route using thiolated microspheres. Drug Deliv 20:210–15
  • Nii T, Ishii F. (2005). Encapsulation efficiency of water-soluble and insoluble drugs in liposomes prepared by the microencapsulation vesicle method. Int J Pharm 298:198–205
  • Ning MY, Guo YZ, Pan HZ, et al. (2005). Preparation and evaluation of proliposomes containing clotrimazole. Chem Pharm Bull 53:620–4
  • Ozsoy Y, Gungor S, Cevher E. (2009). Nasal delivery of high molecular weight drugs. Molecules 14:3754–79
  • Packer M, Fowler MB, Roecker EB, et al. (2002). Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study. Circulation 106:2194–9
  • Quadir M, Zia H, Needham TE. (2000). Development and evaluation of nasal formulations of ketorolac. Drug Deliv 7:223–9
  • Rajanikanth PS, Sankar C, Mishra B. (2003). Sodium alginate microspheres of metoprolol tartrate for intranasal systemic delivery: development and evaluation. Drug Deliv 10:21–8
  • Salama HA, Mahmoud AA, Kamel AO, et al. (2012a). Brain delivery of olanzapine by intranasal administration of transfersomal vesicles. J Liposome Res 22:336–45
  • Salama HA, Mahmoud AA, Kamel AO, et al. (2012b). Phospholipid based colloidal poloxamer–nanocubic vesicles for brain targeting via the nasal route. Colloids Surf B Biointerfaces 100:146–54
  • Senior JH. (1987). Fate and behavior of liposomes in vivo: a review of controlling factors. Crit Rev Ther Drug Carrier Syst 3:123–93
  • Shahrokh Z, Nichols AV. (1982). Particle size interconversion of human low density lipoproteins during incubation of plasma with phosphatidylcholine vesicles. Biochem Biophys Res Commun 108:888–95
  • Srivastava RC, Nagappa AN. (2005). Application of surface activity in therapeutics, 1st ed., Amsterdam: Elsevier, North-Holland Biomedical Press
  • Tengamnuay P, Sahamethapat A, Sailasuta A, Mitra AK. (2000). Chitosans as nasal absorption enhancers of peptides: comparison between free amine chitosans and soluble salts. Int J Pharm 197:53–67
  • Thummel KE, Shen DD. (2001). Design and optimization of dosage regimens: pharmacokinetic data. In: Hardman JG, Limbirel LE, Gilman AG, eds. Goodman and Gilman's. The pharmacological basis of therapeutics, 10th ed., New York: McGraw Hill, 1936–40
  • Van den Bergh BA, Wertz PW, Junginger HE, Bouwstra JA. (2001). Elasticity of vesicles assessed by electron spin resonance, electron microscopy and extrusion measurements. Int J Pharm 217:13–24
  • Varshosaz J, Sadrai H, Heidari A. (2006). Nasal delivery of insulin using bioadhesive chitosan gels. Drug Deliv 13:1–38
  • Vyas SP, Goswami SK, Singh R. (1995). Liposomes based nasal delivery system of nifedipine: development and characterization. Int J Pharm 118:23–30
  • Yoshioka T, Sternberg B, Florence AT. (1994). Preparation and properties of vesicles (niosomes) of sorbitan monoesters (Span 20, 40, 60, and 80) and a sorbitan triester (Span 85). Int J Pharm 105:1–6
  • Young JT, Johnston PK, Pace WG, Mishra KA. (2004). Phospholipid-stabilized nanoparticles of cyclosporine A by rapid expansion from supercritical to aqueous solution. AAPS PharmSciTech 5:E11
  • Zaki NM, Awad GA, Mortada ND, Abd Elhady SS. (2007). Enhanced bioavailability of metoclopramide HCl by intranasal administration of a mucoadhesive in situ gel with modulated rheological and mucociliary transport properties. Eur J Pharm Sci 32:296–307

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.